HSPT
Horizon Space Acquisition II Corp.10.62
+0.06+0.57%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
96.43MP/E (TTM)
53.10Basic EPS (TTM)
0.20Dividend Yield
0%Recent Filings
8-K
SPAC deadline extended one month
Horizon Space Acquisition II extended its deadline to complete its initial business combination by one month to March 18, 2026, via a $50,000 trust deposit from William Wang, CEO of target SL Bio. The company issued him a non-interest-bearing promissory note, convertible into private units at $10.00 each upon closing. Redemptions hit hard: 2,012,378 shares for the business combination, 4,709,337 for the extension. Time bought, but pressure mounts.
8-K
SPAC approves SPAC merger, extension
Horizon Space Acquisition II shareholders approved the Business Combination with SL Bio via dual Cayman mergers under the May 2025 agreement, plus MAA and Trust amendments extending the deadline from February 18, 2026, to up to February 18, 2027, via up to 12 monthly deposits of the lesser of $50,000 or $0.033 per public share. Votes passed decisively: 5M+ for, ~1.2M against in the key EGM. Deal awaits closing conditions.
8-K
Proxy adds two independents
Horizon Space Acquisition II supplemented its proxy ahead of the February 12 shareholder vote on merging with SL Bio, adding Joseph Levinson and Qian Xu as independent director nominees for post-combination PubCo. Levinson brings 25+ years in accounting and cross-border compliance; Xu adds investment banking expertise. William Wang retains ~59% control in no/max redemption scenarios. Meeting unchanged.
8-K
Redemption process clarified
Horizon Space Acquisition II Corp. issued a press release on February 3, 2026, clarifying the redemption process for its February 12 Business Combination vote with SL Bio and the February 13 Extension Meeting to prolong its deal deadline. Public shareholders who elected redemptions for the merger must also submit for the extension by February 11 to lock them in—yet no guarantee the extension happens. Redemptions risk draining trust cash, threatening deal closure.
8-K
SPAC meeting postponed
Horizon Space Acquisition II Corp. postponed its extraordinary general meeting on the SL Bio business combination from February 3 to February 12, 2026, buying time to engage shareholders. Record date holds at December 29, 2025; redemption deadline now February 10. No other changes. Deal faces redemption risks.
AACB
Artius II Acquisition Inc.
10.31+0.00
ASPC
A SPAC III Acquisition Corp.
10.50-0.05
ATII
Archimedes Tech SPAC Partners I
10.37-0.01
CNDA
Concord Acquisition Corp II
11.42+0.00
FTII
FutureTech II Acquisition Corp.
12.02+0.00
HOND
HCM II Acquisition Corp.
18.04+0.16
HSPO
Horizon Space Acquisition I Cor
12.17+12.17
HVII
Hennessy Capital Investment Cor
10.30-0.01
SVII
Spring Valley Acquisition Corp.
12.70+0.00
SZZL
Sizzle Acquisition Corp. II
10.17+0.00